Latest News
Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
Newsfile - Mon Nov 18, 10:52AM CST
Newsfile
Mon Nov 18, 10:52AM CST
Marked and rapid reductions in both pericarditis pain and inflammation ย maintained throughout the 26-week studyEpisodes of pericarditis per year substantially reduced MAvERIC-Pilot results support advancing CardiolRxโข into the Phase II/III MAVERIC-2and the Phase III MAVERIC-3 clinical trialsToronto, Ontario--(Newsfile Corp. - November 18, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX:...
Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis
Newsfile - Tue Oct 22, 5:38AM CDT
Newsfile
Tue Oct 22, 5:38AM CDT
MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1 blocker therapy (rilonacept or anakinra) and is expected to run concurrently with the Company's planned Phase III program.Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage...
Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option
Newsfile - Fri Oct 11, 7:44AM CDT
Newsfile
Fri Oct 11, 7:44AM CDT
Oakville, Ontario--(Newsfile Corp. - October 11, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that, further to its...
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares
Newsfile - Thu Oct 10, 8:16AM CDT
Newsfile
Thu Oct 10, 8:16AM CDT
Oakville, Ontario--(Newsfile Corp. - October 10, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, confirmed today that it has successfully closed its...
Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares
Newsfile - Wed Oct 9, 7:12AM CDT
Newsfile
Wed Oct 9, 7:12AM CDT
Oakville, Ontario--(Newsfile Corp. - October 9, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announced today the pricing of its previously announced...
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares
Newsfile - Tue Oct 8, 3:12PM CDT
Newsfile
Tue Oct 8, 3:12PM CDT
Toronto, Ontario--(Newsfile Corp. - October 8, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce the Company has filed...
Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis
Newsfile - Tue Sep 24, 6:44AM CDT
Newsfile
Tue Sep 24, 6:44AM CDT
Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, today announced it has achieved the target patient...
Stocks in play: Cardiol Therapeutics Inc
Baystreet - Tue Sep 10, 9:01AM CDT
Baystreet
Tue Sep 10, 9:01AM CDT
Announced the data from its Phase II open-label MAvERIC-Pilot study investigating the impact of CardiolRxโข ...
Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024
Newsfile - Tue Sep 10, 6:40AM CDT
Newsfile
Tue Sep 10, 6:40AM CDT
Full clinical data will be reported in an oral presentation at the premier global event for advancements in cardiovascular science and medicine on November 18, 2024Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused...
Cardiol Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (CRDL)
AI-generated - The Globe and Mail - Wed Aug 14, 8:22PM CDT
AI-generated - The Globe and Mail
Wed Aug 14, 8:22PM CDT
Cardiol Therapeutics Inc is among the group of top performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price grow at a faster rate than the rest of the market so far this year. This report is generated monthly. It...
Closing Bell: Cardiol Therapeutics Inc down on Wednesday (CRDL)
Automated Summaries - The Globe and Mail - Wed Aug 7, 4:01PM CDT
Automated Summaries - The Globe and Mail
Wed Aug 7, 4:01PM CDT
Closing Bell: Cardiol Therapeutics Inc up on Tuesday (CRDL)
Automated Summaries - The Globe and Mail - Tue Aug 6, 4:02PM CDT
Automated Summaries - The Globe and Mail
Tue Aug 6, 4:02PM CDT
Closing Bell: Cardiol Therapeutics Inc down on Friday (CRDL)
Automated Summaries - The Globe and Mail - Mon Aug 5, 4:01PM CDT
Automated Summaries - The Globe and Mail
Mon Aug 5, 4:01PM CDT
Closing Bell: Cardiol Therapeutics Inc down on Friday (CRDL)
Automated Summaries - The Globe and Mail - Fri Aug 2, 4:01PM CDT
Automated Summaries - The Globe and Mail
Fri Aug 2, 4:01PM CDT
Closing Bell: Cardiol Therapeutics Inc down on Thursday (CRDL)
Automated Summaries - The Globe and Mail - Thu Aug 1, 4:01PM CDT
Automated Summaries - The Globe and Mail
Thu Aug 1, 4:01PM CDT
Closing Bell: Cardiol Therapeutics Inc down on Wednesday (CRDL)
Automated Summaries - The Globe and Mail - Wed Jul 31, 4:02PM CDT
Automated Summaries - The Globe and Mail
Wed Jul 31, 4:02PM CDT
Closing Bell: Cardiol Therapeutics Inc down on Tuesday (CRDL)
Automated Summaries - The Globe and Mail - Tue Jul 30, 4:02PM CDT
Automated Summaries - The Globe and Mail
Tue Jul 30, 4:02PM CDT
Closing Bell: Cardiol Therapeutics Inc flat on Monday (CRDL)
Automated Summaries - The Globe and Mail - Mon Jul 29, 4:02PM CDT
Automated Summaries - The Globe and Mail
Mon Jul 29, 4:02PM CDT
Closing Bell: Cardiol Therapeutics Inc up on Friday (CRDL)
Automated Summaries - The Globe and Mail - Fri Jul 26, 4:01PM CDT
Automated Summaries - The Globe and Mail
Fri Jul 26, 4:01PM CDT
Closing Bell: Cardiol Therapeutics Inc up on Thursday (CRDL)
Automated Summaries - The Globe and Mail - Thu Jul 25, 4:01PM CDT
Automated Summaries - The Globe and Mail
Thu Jul 25, 4:01PM CDT
Closing Bell: Cardiol Therapeutics Inc down on Wednesday (CRDL)
Automated Summaries - The Globe and Mail - Wed Jul 24, 4:02PM CDT
Automated Summaries - The Globe and Mail
Wed Jul 24, 4:02PM CDT
Closing Bell: Cardiol Therapeutics Inc up on Tuesday (CRDL)
Automated Summaries - The Globe and Mail - Tue Jul 23, 4:02PM CDT
Automated Summaries - The Globe and Mail
Tue Jul 23, 4:02PM CDT
Closing Bell: Cardiol Therapeutics Inc up on Monday (CRDL)
Automated Summaries - The Globe and Mail - Mon Jul 22, 4:02PM CDT
Automated Summaries - The Globe and Mail
Mon Jul 22, 4:02PM CDT
Closing Bell: Cardiol Therapeutics Inc up on Friday (CRDL)
Automated Summaries - The Globe and Mail - Fri Jul 19, 4:01PM CDT
Automated Summaries - The Globe and Mail
Fri Jul 19, 4:01PM CDT
Closing Bell: Cardiol Therapeutics Inc down on Thursday (CRDL)
Automated Summaries - The Globe and Mail - Thu Jul 18, 4:01PM CDT
Automated Summaries - The Globe and Mail
Thu Jul 18, 4:01PM CDT